Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Gefunden in
Art der Quelle
Schlagwort
- monoclonal antibodies 6 Treffer
- clinical trials 4 Treffer
- biological products except diagnostic 3 Treffer
- business 3 Treffer
- diagnostic substances 3 Treffer
-
40 weitere Werte:
- news, opinion and commentary 3 Treffer
- united states. food and drug administration 3 Treffer
- biological products 2 Treffer
- biological products industry -- product development 2 Treffer
- drug approval 2 Treffer
- atopic dermatitis 1 Treffer
- biological products -- product development 1 Treffer
- biological products -- rankings 1 Treffer
- biological products exc. diagnostic 1 Treffer
- biological products industry -- mergers, acquisitions and divestments 1 Treffer
- biotechnology industry -- mergers, acquisitions and divestments 1 Treffer
- commercial developers 1 Treffer
- commercial physical research 1 Treffer
- company acquisition/merger 1 Treffer
- company joint venture 1 Treffer
- csl ltd. (parkville, victoria) 1 Treffer
- herceptin (medication) 1 Treffer
- hospira inc. 1 Treffer
- humira (medication) 1 Treffer
- immunoglobulin g 1 Treffer
- inland real estate corp. -- joint ventures 1 Treffer
- interleukins 1 Treffer
- ipilimumab 1 Treffer
- lung cancer, non-small cell -- drug therapy 1 Treffer
- manufacturing costs -- statistics 1 Treffer
- noncommercial research organizations 1 Treffer
- pharmaceutical industry 1 Treffer
- pharmacy 1 Treffer
- prolia (medication) 1 Treffer
- psoriasis 1 Treffer
- real estate industry -- joint ventures 1 Treffer
- real estate investment trusts -- joint ventures 1 Treffer
- real property 1 Treffer
- remicade (medication) 1 Treffer
- rheumatoid factor 1 Treffer
- shopping centers 1 Treffer
- stelara (medication) 1 Treffer
- synagis (medication) 1 Treffer
- ulcerative colitis 1 Treffer
- xgeva (medication) 1 Treffer
Verlag
Publikation
Sprache
Geographischer Bezug
11 Treffer
-
In: PR Newswire, 2023-08-15ZeitungsartikelZugriff:
-
In: PR Newswire, 2023-02-06ZeitungsartikelZugriff:
-
-
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA.In: PR Newswire, 2021-07-06ZeitungsartikelZugriff:
-
In: PR Newswire, 2019-11-07ZeitungsartikelZugriff:
-
In: PR Newswire, 2018-10-23ZeitungsartikelZugriff:
-
In: PR Newswire, 2015-08-19ZeitungsartikelZugriff:
-
In: States News Service, 2015-08-25ZeitungsartikelZugriff:
-
In: PR Newswire, 2020-06-08ZeitungsartikelZugriff:
-
In: Entertainment Close-up, 2013-11-18serialPeriodicalZugriff:
-
NeuClone Discloses Details of its Fifth Product: A Biosimilar Candidate for Prolia/XGEVA (Denosumab)In: PR Newswire, 2018-01-08ZeitungsartikelZugriff: